Drugs / K-755
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03414294 | Feb 2018 → Nov 2019 | — | Kowa Company, Ltd. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | K-755 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03414294 ↗ |
| Route | Oral | “K-755 tablet orally” NCT03414294 ↗ |